Market Research Logo

Europe Market Report for Dental Growth Factor 2017 - MedCore

Europe Market Report for Dental Growth Factor 2017 - MedCore

Dental growth factor and tissue engineering products is a broad category that encompasses products used for facilitating and enhancing bone regeneration. This includes growth factors and enamel matrix protein solutions. Platelet rich plasma (PRP) is also used for these purposes, but will not be considered within this report. Osteoinductivity refers to the ability of a graft to induce de novo bone growth with biomimetic substances. However, only a few bone graft substitute materials have the capacity for osteoinductivity. Growth factors and other tissue engineering products enhance osteoinductivity and osteogenesis, and are used to increase the rate and volume of bone regeneration.

General Report Contents

  • Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
  • Market Drivers & Limiters for each chapter segment
  • Competitive Analysis for each chapter segment
  • Section on recent mergers & acquisitions
Emdogain® is used in periodontal surgery and as a topical application for exposed root surfaces, and is indicated for the treatment of intra-bony defects due to moderate or severe periodontitis. In the past, Emdogain® was typically only incorporated into periodontal procedure in Europe, as it is considered to be extremely effective for stimulating bone regeneration to treat certain periodontal defects. However, in May 2016 the product was cleared for a new indication of soft-tissue wound healing in oral surgical procedures and dental implantation procedures in general. Therefore, the European market for Emdogain® will emulate growth of periodontal defects within the region but additionally incorporate a portion of growth within the DBGS market. Generally, the number of periodontal procedures per country is strongly correlated with the country’s population. However, Emdogain® has benefited from substantial marketing campaigns by Straumann since 2009 that advocated introducing the product as a resource for general practitioners to create new treatment opportunities in order to mitigate the effects of the recession."


EXECUTIVE SUMMARY
EUROPEAN DENTAL BONE GRAFT SUBSTITUTE AND OTHER BIOMATERIALS MARKET OVERVIEW
COMPETITIVE ANALYSIS
MARKET TRENDS
MARKET DEVELOPMENTS
PROCEDURES INCLUDED
MARKETS INCLUDED
VERSION HISTORY
RESEARCH METHODOLOGY
1.1 RESEARCH SCOPE
1.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
DISEASE OVERVIEW
2.1 BASIC ANATOMY
2.1.1 Dental Anatomy: Oral Cavity and Intraoral landmarks
2.2 DISEASE PATHOLOGY AND DISORDERS
2.2.1 General Diagnostics
2.2.2 Indication for Dental Implant
2.2.2.1 Periodontal Disease
2.2.2.2 Dental Implant Procedures
2.3 PATIENT DEMOGRAPHICS
2.3.1 General Dental Statistics
2.3.2 Tooth Loss Statistics
PRODUCT ASSESSMENT
3.1 PRODUCT PORTFOLIOS
3.1.1 Dental Bone Graft Substitutes
3.1.1.1 Dental Growth Factor Products
3.2 REGULATORY ISSUES AND RECALLS
3.2.1 Dental Bone Graft Substitutes
3.3 CLINICAL TRIALS
3.3.1 Dental Bone Graft Substitutes
COUNTRY PROFILES
4.1 INTRODUCTION
4.1.1.1 Population
4.1.1.2 GDP per Capita
4.1.1.3 Dental Bone Graft Substitute Procedures per 10,000 Inhabitants
4.1.1.4 Price Index
4.2 GERMANY
4.3 FRANCE
4.4 UNITED KINGDOM
4.5 ITALY
4.6 SPAIN
4.7 BENELUX
4.8 SCANDINAVIA
4.9 AUSTRIA
4.10 SWITZERLAND
4.11 PORTUGAL
DENTAL GROWTH FACTOR MARKET
5.1 INTRODUCTION
5.2 MARKET ANALYSIS AND FORECAST
5.2.1 Emdogain® Market
5.3 DRIVERS AND LIMITERS
5.3.1 Market Drivers
5.3.2 Market Limiters
5.4 EMERGING COMPETITORS AND TECHNOLOGIES
5.4.1 GEM 21S®
5.4.2 INFUSE®
5.4.3 Platelet Rich Plasma (PRP)
5.4.4 Osteocel®
ABBREVIATIONS
APPENDIX: COMPANY PRESS RELEASES
List of Charts
Chart 1 1: Dental Bone Graft Substitute and Other Biomaterials Market by Segment, Europe, 2013 – 2023
Chart 1 2: Dental Bone Graft Substitute and Other Biomaterials Market Overview, Europe, 2016 & 2023
Chart 4 1: Country Profile, Germany, 2016
Chart 4 2: Country Profile, France, 2016
Chart 4 3: Country Profile, United Kingdom, 2016
Chart 4 4: Country Profile, Italy, 2016
Chart 4 5: Country Profile, Spain, 2016
Chart 4 6: Country Profile, Benelux, 2016
Chart 4 7: Country Profile, Scandinavia, 2016
Chart 4 8: Country Profile, Austria, 2016
Chart 4 9: Country Profile, Switzerland, 2016
Chart 4 10: Country Profile, Portugal, 2016
Chart 5 1: Emdogain® Market, Europe, 2013 – 2023
List of Figures
Figure 1 1: Dental Bone Graft Substitute and Other Biomaterials Market Share Ranking by Segment, Europe, 2016
Figure 1 2: Companies Researched in this Report, Europe, 2016
Figure 1 3: Factors Impacting the Dental Bone Graft Substitute and Other Biomaterials Market by Segment, Europe
Figure 1 4: Recent Events in the Dental Bone Graft Substitute and Other Biomaterials Market, Europe, 2013 – 2016
Figure 1 5: Dental Bone Graft Substitute and Other Biomaterials Procedures Covered, Europe, 2016
Figure 1 6: Dental Bone Graft Substitute and Other Biomaterials Markets Covered, Europe, 2016
Figure 1 7: Version History
Figure 3 1: Dental Growth Products by Company
Figure 3 2: Class 3 Device Recall ZCORE Syringe
Figure 3 3: Class 2 Device Recall Collagen Matrix Inc.
Figure 3 4: Class 2 Device Recall Endobon Xenograft Granules, Biomet France SARL
Figure 3 5: Class 3 Device Recall ENDOBON XENOGRAFT GRANULES 0.5 ML
Figure 3 6: Effect of Mucograft® Seal on Post-extraction Ridge Preservation Using Bone Allograft (Mucograft)
Figure 3 7: Prospective, Comparative Assessment of Alveolar Bone Augmentation Using GUIDOR® Membrane
Figure 3 8: Evaluation of Zimmer Puros® Allograft vs. Creos™ Allograft for Alveolar Ridge Preservation
Figure 3 9: Guided Bone Regeneration Using Synthetic Membrane
Figure 3 10: Histological Comparison of Ridge Preservation Using Mineralized FDBA Alone Versus a Combined Mineralized-Demineralized Freeze Dried Bone Allograft
Figure 3 11: A Randomized Control Trial Testing Connective Tissue Grafts vs. Allograft on Dental Implants
Figure 5 1: Emdogain® Market, Europe, 2013 – 2023
Figure 5 2: Units Sold by Country, Emdogain® Market, Europe, 2013 – 2023
Figure 5 3: Average Selling Price by Country, Emdogain® Market, Europe, 2013 – 2023 (€)
Figure 5 4: Average Selling Price by Country, Emdogain® Market, Europe, 2013 – 2023 (US$)
Figure 5 5: Market Value by Country, Emdogain® Market, Europe, 2013 – 2023 (€M)
Figure 5 6: Market Value by Country, Emdogain® Market, Europe, 2013 – 2023 (US$M)
Figure 5 7: Drivers and Limiters, Dental Growth Factor Market, Europe, 2016
Figure 7 1: Press Release Summary

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report